Literature DB >> 9458231

Risk factors for avascular necrosis in systemic lupus erythematosus.

L Cozen, D J Wallace.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9458231

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

1.  Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.

Authors:  J Calvo-Alén; G McGwin; S Toloza; M Fernández; J M Roseman; H M Bastian; E J Cepeda; E B González; B A Baethge; B J Fessler; L M Vilá; J D Reveille; G S Alarcón
Journal:  Ann Rheum Dis       Date:  2005-11-03       Impact factor: 19.103

Review 2.  Osteonecrosis in patients with SLE.

Authors:  Mahmoud Abu-Shakra; Dan Buskila; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

3.  A case of SLE with bilateral osteonecrosis of femoral heads and bone infarct in distal of femur.

Authors:  Mansour Salesi; Mansoor Karimifar; Peyman Mottaghi; Zahra Sayedbonakdar; Hadi Karimzadeh
Journal:  Rheumatol Int       Date:  2009-05-18       Impact factor: 2.631

Review 4.  Glucocorticoid-induced osteonecrosis in systemic lupus erythematosus patients.

Authors:  Kaichi Kaneko; Hao Chen; Matthew Kaufman; Isaak Sverdlov; Emily M Stein; Kyung-Hyun Park-Min
Journal:  Clin Transl Med       Date:  2021-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.